1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Acute Myeloid Leukaemia Therapeutics Market Size (2020-2031) 2.1.2 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) 2.1.3 World Current & Future Analysis for Acute Myeloid Leukaemia Therapeutics by Country/Region (2020, 2024 & 2031) 2.2 Acute Myeloid Leukaemia Therapeutics Segment by Type 2.2.1 Chemotherapy 2.2.2 Targeted Therapy 2.2.3 Immunotherapy 2.2.4 Hypomethylating Agents 2.2.5 Others 2.3 Acute Myeloid Leukaemia Therapeutics Market Size by Type 2.3.1 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) 2.3.2 Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2020-2025) 2.4 Acute Myeloid Leukaemia Therapeutics Segment by Application 2.4.1 Specialty Clinics 2.4.2 Hospital 2.4.3 Others 2.5 Acute Myeloid Leukaemia Therapeutics Market Size by Application 2.5.1 Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) 2.5.2 Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2020-2025) 3 Acute Myeloid Leukaemia Therapeutics Market Size by Player 3.1 Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Player 3.1.1 Global Acute Myeloid Leukaemia Therapeutics Revenue by Player (2020-2025) 3.1.2 Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player (2020-2025) 3.2 Global Acute Myeloid Leukaemia Therapeutics Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Acute Myeloid Leukaemia Therapeutics by Region 4.1 Acute Myeloid Leukaemia Therapeutics Market Size by Region (2020-2025) 4.2 Global Acute Myeloid Leukaemia Therapeutics Annual Revenue by Country/Region (2020-2025) 4.3 Americas Acute Myeloid Leukaemia Therapeutics Market Size Growth (2020-2025) 4.4 APAC Acute Myeloid Leukaemia Therapeutics Market Size Growth (2020-2025) 4.5 Europe Acute Myeloid Leukaemia Therapeutics Market Size Growth (2020-2025) 4.6 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Growth (2020-2025) 5 Americas 5.1 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Country (2020-2025) 5.2 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) 5.3 Americas Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Region (2020-2025) 6.2 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) 6.3 APAC Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Country (2020-2025) 7.2 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) 7.3 Europe Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Acute Myeloid Leukaemia Therapeutics by Region (2020-2025) 8.2 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) 8.3 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Acute Myeloid Leukaemia Therapeutics Market Forecast 10.1 Global Acute Myeloid Leukaemia Therapeutics Forecast by Region (2026-2031) 10.1.1 Global Acute Myeloid Leukaemia Therapeutics Forecast by Region (2026-2031) 10.1.2 Americas Acute Myeloid Leukaemia Therapeutics Forecast 10.1.3 APAC Acute Myeloid Leukaemia Therapeutics Forecast 10.1.4 Europe Acute Myeloid Leukaemia Therapeutics Forecast 10.1.5 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Forecast 10.2 Americas Acute Myeloid Leukaemia Therapeutics Forecast by Country (2026-2031) 10.2.1 United States Market Acute Myeloid Leukaemia Therapeutics Forecast 10.2.2 Canada Market Acute Myeloid Leukaemia Therapeutics Forecast 10.2.3 Mexico Market Acute Myeloid Leukaemia Therapeutics Forecast 10.2.4 Brazil Market Acute Myeloid Leukaemia Therapeutics Forecast 10.3 APAC Acute Myeloid Leukaemia Therapeutics Forecast by Region (2026-2031) 10.3.1 China Acute Myeloid Leukaemia Therapeutics Market Forecast 10.3.2 Japan Market Acute Myeloid Leukaemia Therapeutics Forecast 10.3.3 Korea Market Acute Myeloid Leukaemia Therapeutics Forecast 10.3.4 Southeast Asia Market Acute Myeloid Leukaemia Therapeutics Forecast 10.3.5 India Market Acute Myeloid Leukaemia Therapeutics Forecast 10.3.6 Australia Market Acute Myeloid Leukaemia Therapeutics Forecast 10.4 Europe Acute Myeloid Leukaemia Therapeutics Forecast by Country (2026-2031) 10.4.1 Germany Market Acute Myeloid Leukaemia Therapeutics Forecast 10.4.2 France Market Acute Myeloid Leukaemia Therapeutics Forecast 10.4.3 UK Market Acute Myeloid Leukaemia Therapeutics Forecast 10.4.4 Italy Market Acute Myeloid Leukaemia Therapeutics Forecast 10.4.5 Russia Market Acute Myeloid Leukaemia Therapeutics Forecast 10.5 Middle East & Africa Acute Myeloid Leukaemia Therapeutics Forecast by Region (2026-2031) 10.5.1 Egypt Market Acute Myeloid Leukaemia Therapeutics Forecast 10.5.2 South Africa Market Acute Myeloid Leukaemia Therapeutics Forecast 10.5.3 Israel Market Acute Myeloid Leukaemia Therapeutics Forecast 10.5.4 Turkey Market Acute Myeloid Leukaemia Therapeutics Forecast 10.6 Global Acute Myeloid Leukaemia Therapeutics Forecast by Type (2026-2031) 10.7 Global Acute Myeloid Leukaemia Therapeutics Forecast by Application (2026-2031) 10.7.1 GCC Countries Market Acute Myeloid Leukaemia Therapeutics Forecast 11 Key Players Analysis 11.1 Pfizer Inc. 11.1.1 Pfizer Inc. Company Information 11.1.2 Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Product Offered 11.1.3 Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.1.4 Pfizer Inc. Main Business Overview 11.1.5 Pfizer Inc. Latest Developments 11.2 Novartis AG 11.2.1 Novartis AG Company Information 11.2.2 Novartis AG Acute Myeloid Leukaemia Therapeutics Product Offered 11.2.3 Novartis AG Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.2.4 Novartis AG Main Business Overview 11.2.5 Novartis AG Latest Developments 11.3 Celgene Corporation 11.3.1 Celgene Corporation Company Information 11.3.2 Celgene Corporation Acute Myeloid Leukaemia Therapeutics Product Offered 11.3.3 Celgene Corporation Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.3.4 Celgene Corporation Main Business Overview 11.3.5 Celgene Corporation Latest Developments 11.4 Astellas Pharma Inc. 11.4.1 Astellas Pharma Inc. Company Information 11.4.2 Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Product Offered 11.4.3 Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.4.4 Astellas Pharma Inc. Main Business Overview 11.4.5 Astellas Pharma Inc. Latest Developments 11.5 Daiichi Sankyo Company, Limited 11.5.1 Daiichi Sankyo Company, Limited Company Information 11.5.2 Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Product Offered 11.5.3 Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.5.4 Daiichi Sankyo Company, Limited Main Business Overview 11.5.5 Daiichi Sankyo Company, Limited Latest Developments 11.6 Jazz Pharmaceuticals 11.6.1 Jazz Pharmaceuticals Company Information 11.6.2 Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Product Offered 11.6.3 Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.6.4 Jazz Pharmaceuticals Main Business Overview 11.6.5 Jazz Pharmaceuticals Latest Developments 11.7 Boehringer Ingelheim International GmbH 11.7.1 Boehringer Ingelheim International GmbH Company Information 11.7.2 Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Product Offered 11.7.3 Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.7.4 Boehringer Ingelheim International GmbH Main Business Overview 11.7.5 Boehringer Ingelheim International GmbH Latest Developments 11.8 Johnson & Johnson 11.8.1 Johnson & Johnson Company Information 11.8.2 Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Product Offered 11.8.3 Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.8.4 Johnson & Johnson Main Business Overview 11.8.5 Johnson & Johnson Latest Developments 11.9 Gilead Sciences, Inc. 11.9.1 Gilead Sciences, Inc. Company Information 11.9.2 Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered 11.9.3 Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.9.4 Gilead Sciences, Inc. Main Business Overview 11.9.5 Gilead Sciences, Inc. Latest Developments 11.10 Amgen Inc. 11.10.1 Amgen Inc. Company Information 11.10.2 Amgen Inc. Acute Myeloid Leukaemia Therapeutics Product Offered 11.10.3 Amgen Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.10.4 Amgen Inc. Main Business Overview 11.10.5 Amgen Inc. Latest Developments 11.11 Takeda Pharmaceutical Company Limited 11.11.1 Takeda Pharmaceutical Company Limited Company Information 11.11.2 Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Product Offered 11.11.3 Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.11.4 Takeda Pharmaceutical Company Limited Main Business Overview 11.11.5 Takeda Pharmaceutical Company Limited Latest Developments 11.12 Sunesis Pharmaceuticals, Inc. 11.12.1 Sunesis Pharmaceuticals, Inc. Company Information 11.12.2 Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered 11.12.3 Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.12.4 Sunesis Pharmaceuticals, Inc. Main Business Overview 11.12.5 Sunesis Pharmaceuticals, Inc. Latest Developments 11.13 Agios Pharmaceuticals, Inc. 11.13.1 Agios Pharmaceuticals, Inc. Company Information 11.13.2 Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered 11.13.3 Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue, Gross Margin and Market Share (2020-2025) 11.13.4 Agios Pharmaceuticals, Inc. Main Business Overview 11.13.5 Agios Pharmaceuticals, Inc. Latest Developments 12 Research Findings and Conclusion
List of Tables Table 1. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions) Table 2. Acute Myeloid Leukaemia Therapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions) Table 3. Major Players of Chemotherapy Table 4. Major Players of Targeted Therapy Table 5. Major Players of Immunotherapy Table 6. Major Players of Hypomethylating Agents Table 7. Major Players of Others Table 8. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions) Table 9. Global Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 10. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2020-2025) Table 11. Acute Myeloid Leukaemia Therapeutics Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions) Table 12. Global Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 13. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2020-2025) Table 14. Global Acute Myeloid Leukaemia Therapeutics Revenue by Player (2020-2025) & ($ millions) Table 15. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player (2020-2025) Table 16. Acute Myeloid Leukaemia Therapeutics Key Players Head office and Products Offered Table 17. Acute Myeloid Leukaemia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) Table 18. New Products and Potential Entrants Table 19. Mergers & Acquisitions, Expansion Table 20. Global Acute Myeloid Leukaemia Therapeutics Market Size by Region (2020-2025) & ($ millions) Table 21. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2020-2025) Table 22. Global Acute Myeloid Leukaemia Therapeutics Revenue by Country/Region (2020-2025) & ($ millions) Table 23. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Country/Region (2020-2025) Table 24. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Country (2020-2025) & ($ millions) Table 25. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country (2020-2025) Table 26. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 27. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2020-2025) Table 28. Americas Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 29. Americas Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2020-2025) Table 30. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Region (2020-2025) & ($ millions) Table 31. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2020-2025) Table 32. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 33. APAC Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 34. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Country (2020-2025) & ($ millions) Table 35. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country (2020-2025) Table 36. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 37. Europe Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 38. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Region (2020-2025) & ($ millions) Table 39. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Type (2020-2025) & ($ millions) Table 40. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size by Application (2020-2025) & ($ millions) Table 41. Key Market Drivers & Growth Opportunities of Acute Myeloid Leukaemia Therapeutics Table 42. Key Market Challenges & Risks of Acute Myeloid Leukaemia Therapeutics Table 43. Key Industry Trends of Acute Myeloid Leukaemia Therapeutics Table 44. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Region (2026-2031) & ($ millions) Table 45. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Region (2026-2031) Table 46. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Type (2026-2031) & ($ millions) Table 47. Global Acute Myeloid Leukaemia Therapeutics Market Size Forecast by Application (2026-2031) & ($ millions) Table 48. Pfizer Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 49. Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Product Offered Table 50. Pfizer Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 51. Pfizer Inc. Main Business Table 52. Pfizer Inc. Latest Developments Table 53. Novartis AG Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 54. Novartis AG Acute Myeloid Leukaemia Therapeutics Product Offered Table 55. Novartis AG Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 56. Novartis AG Main Business Table 57. Novartis AG Latest Developments Table 58. Celgene Corporation Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 59. Celgene Corporation Acute Myeloid Leukaemia Therapeutics Product Offered Table 60. Celgene Corporation Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 61. Celgene Corporation Main Business Table 62. Celgene Corporation Latest Developments Table 63. Astellas Pharma Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 64. Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Product Offered Table 65. Astellas Pharma Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 66. Astellas Pharma Inc. Main Business Table 67. Astellas Pharma Inc. Latest Developments Table 68. Daiichi Sankyo Company, Limited Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 69. Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Product Offered Table 70. Daiichi Sankyo Company, Limited Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 71. Daiichi Sankyo Company, Limited Main Business Table 72. Daiichi Sankyo Company, Limited Latest Developments Table 73. Jazz Pharmaceuticals Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 74. Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Product Offered Table 75. Jazz Pharmaceuticals Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 76. Jazz Pharmaceuticals Main Business Table 77. Jazz Pharmaceuticals Latest Developments Table 78. Boehringer Ingelheim International GmbH Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 79. Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Product Offered Table 80. Boehringer Ingelheim International GmbH Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 81. Boehringer Ingelheim International GmbH Main Business Table 82. Boehringer Ingelheim International GmbH Latest Developments Table 83. Johnson & Johnson Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 84. Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Product Offered Table 85. Johnson & Johnson Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 86. Johnson & Johnson Main Business Table 87. Johnson & Johnson Latest Developments Table 88. Gilead Sciences, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 89. Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered Table 90. Gilead Sciences, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 91. Gilead Sciences, Inc. Main Business Table 92. Gilead Sciences, Inc. Latest Developments Table 93. Amgen Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 94. Amgen Inc. Acute Myeloid Leukaemia Therapeutics Product Offered Table 95. Amgen Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 96. Amgen Inc. Main Business Table 97. Amgen Inc. Latest Developments Table 98. Takeda Pharmaceutical Company Limited Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 99. Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Product Offered Table 100. Takeda Pharmaceutical Company Limited Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 101. Takeda Pharmaceutical Company Limited Main Business Table 102. Takeda Pharmaceutical Company Limited Latest Developments Table 103. Sunesis Pharmaceuticals, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 104. Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered Table 105. Sunesis Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 106. Sunesis Pharmaceuticals, Inc. Main Business Table 107. Sunesis Pharmaceuticals, Inc. Latest Developments Table 108. Agios Pharmaceuticals, Inc. Details, Company Type, Acute Myeloid Leukaemia Therapeutics Area Served and Its Competitors Table 109. Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Product Offered Table 110. Agios Pharmaceuticals, Inc. Acute Myeloid Leukaemia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2025) Table 111. Agios Pharmaceuticals, Inc. Main Business Table 112. Agios Pharmaceuticals, Inc. Latest Developments List of Figures Figure 1. Acute Myeloid Leukaemia Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Acute Myeloid Leukaemia Therapeutics Market Size Growth Rate (2020-2031) ($ millions) Figure 6. Acute Myeloid Leukaemia Therapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions) Figure 7. Acute Myeloid Leukaemia Therapeutics Sales Market Share by Country/Region (2024) Figure 8. Acute Myeloid Leukaemia Therapeutics Sales Market Share by Country/Region (2020, 2024 & 2031) Figure 9. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type in 2024 Figure 10. Acute Myeloid Leukaemia Therapeutics in Specialty Clinics Figure 11. Global Acute Myeloid Leukaemia Therapeutics Market: Specialty Clinics (2020-2025) & ($ millions) Figure 12. Acute Myeloid Leukaemia Therapeutics in Hospital Figure 13. Global Acute Myeloid Leukaemia Therapeutics Market: Hospital (2020-2025) & ($ millions) Figure 14. Acute Myeloid Leukaemia Therapeutics in Others Figure 15. Global Acute Myeloid Leukaemia Therapeutics Market: Others (2020-2025) & ($ millions) Figure 16. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application in 2024 Figure 17. Global Acute Myeloid Leukaemia Therapeutics Revenue Market Share by Player in 2024 Figure 18. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2020-2025) Figure 19. Americas Acute Myeloid Leukaemia Therapeutics Market Size 2020-2025 ($ millions) Figure 20. APAC Acute Myeloid Leukaemia Therapeutics Market Size 2020-2025 ($ millions) Figure 21. Europe Acute Myeloid Leukaemia Therapeutics Market Size 2020-2025 ($ millions) Figure 22. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size 2020-2025 ($ millions) Figure 23. Americas Acute Myeloid Leukaemia Therapeutics Value Market Share by Country in 2024 Figure 24. United States Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 25. Canada Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 26. Mexico Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 27. Brazil Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 28. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region in 2024 Figure 29. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2020-2025) Figure 30. APAC Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2020-2025) Figure 31. China Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 32. Japan Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 33. South Korea Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 34. Southeast Asia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 35. India Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 36. Australia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 37. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Country in 2024 Figure 38. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2020-2025) Figure 39. Europe Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2020-2025) Figure 40. Germany Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 41. France Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 42. UK Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 43. Italy Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 44. Russia Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 45. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Region (2020-2025) Figure 46. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Type (2020-2025) Figure 47. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size Market Share by Application (2020-2025) Figure 48. Egypt Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 49. South Africa Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 50. Israel Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 51. Turkey Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 52. GCC Countries Acute Myeloid Leukaemia Therapeutics Market Size Growth 2020-2025 ($ millions) Figure 53. Americas Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 54. APAC Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 55. Europe Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 56. Middle East & Africa Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 57. United States Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 58. Canada Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 59. Mexico Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 60. Brazil Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 61. China Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 62. Japan Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 63. Korea Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 64. Southeast Asia Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 65. India Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 66. Australia Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 67. Germany Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 68. France Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 69. UK Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 70. Italy Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 71. Russia Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 72. Egypt Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 73. South Africa Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 74. Israel Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 75. Turkey Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions) Figure 76. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Type (2026-2031) Figure 77. Global Acute Myeloid Leukaemia Therapeutics Market Size Market Share Forecast by Application (2026-2031) Figure 78. GCC Countries Acute Myeloid Leukaemia Therapeutics Market Size 2026-2031 ($ millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer Inc.|||Novartis AG|||Celgene Corporation|||Astellas Pharma Inc.|||Daiichi Sankyo Company, Limited|||Jazz Pharmaceuticals|||Boehringer Ingelheim International GmbH|||Johnson & Johnson|||Gilead Sciences, Inc.|||Amgen Inc.|||Takeda Pharmaceutical Company Limited|||Sunesis Pharmaceuticals, Inc.|||Agios Pharmaceuticals, Inc.